Table 1.
Screening components | Family planning services (provide services in accordance with the appropriate clinical recommendation) | Related preventive health services | ||||
---|---|---|---|---|---|---|
Contraceptive servicesa | Pregnancy testing and counseling | Basic infertility services | Preconception health services | STD servicesb | ||
History | ||||||
Reproductive life planc | Screen | Screen | Screen | Screen | Screen | |
Medical historyc,d | Screen | Screen | Screen | Screen | Screen | Screen |
Current pregnancy statusc | Screen | |||||
Sexual health assessmentc,d | Screen | Screen | Screen | Screen | ||
Intimate partner violencec,d,e | Screen | |||||
Alcohol and other drug usec,d,e | Screen | |||||
Tobacco usec,e | Screen (combined hormonal methods for clients aged ≥35 years) | Screen | ||||
Immunizationsc | Screen | Screen for HPV and HBVf | ||||
Depressionc,e | Screen | |||||
Folic acidc,e | Screen | |||||
Physical examination | ||||||
Height, weight, and BMIc,e | Screen (hormonal methods)g | Screen | Screen | |||
Blood pressurec,e | Screen (combined hormonal methods) | Screenf | ||||
Clinical breast examd | Screen | Screenf | ||||
Pelvic examc,d | Screen (initiating diaphragm or IUD) | Screen (if clinically indicated) | Screen | |||
Signs of androgen excessd | Screen | |||||
Thyroid examd | Screen | |||||
Laboratory testing | ||||||
Pregnancy testd | Screen (if clinically indicated) | Screen | ||||
Chlamydiac,e | Screenh | Screenf | ||||
Gonorrheac,e | Screenh | Screenf | ||||
Syphilisc,e | Screenf | |||||
HIV/AIDSc,e | Screenf | |||||
Hepatitis Cc,e | Screenf | |||||
Diabetesc,e | Screenf | |||||
Cervical cytologye | Screenf | |||||
Mammographye | Screen f |
This table presents highlights from CDC’s recommendations on contraceptive use. However, providers should consult the following guidelines when treating individual patients to obtain more detailed information about specific medical conditions and characteristics (Source: CDC. U.S. medical eligibility criteria for contraceptive use 2010. MMWR. 2010;59 [No.RR-4]).
STD services also promote preconception health, but are listed separately here to highlight their importance in the context of all types of family planning visits. The services listed in this column are for women without symptoms suggestive of an STD.
CDC recommendation.
Professional medical organization recommendation.
U.S. Preventive Services Task Force recommendation.
Indicates that screening is suggested only for those persons at highest risk or for a specific subpopulation with high prevalence of an infection or condition.
Weight (BMI) measurement is not needed to determine medical eligibility for any methods of contraception because all methods can be used (U.S. Medical Eligibility Criteria 1) or generally can be used (U.S. Medical Eligibility Criteria 2) among obese women (Source: CDC. U.S. medical eligibility criteria for contraceptive use 2010. MMWR. 2010;59 [No. 4]). However, measuring weight and calculating BMI at baseline might be helpful for monitoring any changes and counseling women who might be concerned about weight change perceived to be associated with their contraceptive method.
Most women do not require additional STD screening at the time of IUD insertion if they have already been screened according to CDC’s STD treatment guidelines (Source: CDC. Sexually transmitted diseases treatment guidelines, 2010. MMWR. 2010;59 [RR-12]. www.cdc.gov/std/treatment/). If a woman has not been screened according to guidelines, screening can be performed at the time of IUD insertion, and insertion should not be delayed. Women with purulent cervicitis or current chlamydial infection or gonorrhea should not undergo IUD insertion (U.S. Medical Eligibility Criteria 4), and women who have a very high individual likelihood of STI exposure (e.g., those with a currently infected partner) generally should not undergo IUD insertion (U.S. Medical Eligibility Criteria 3) (Source: CDC. U.S. medical eligibility criteria for contraceptive use 2010. MMWR Recomm Rep. 2010;59[RR-4]). For these women, IUD insertion should be delayed until appropriate testing and treatment occurs.
HBV, hepatitis B virus; HPV, human papillomavirus; IUD, intrauterine device; STD, sexually transmitted disease; STI, sexually transmitted infection.